Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial

Published:2024-01 Issue:1 Volume:153 Page:173-181.e10
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Kim Edwin H.^ORCID,Bird J. Andrew,Keet Corinne A.,Virkud Yamini V.,Herlihy Lauren,Ye Ping,Smeekens Johanna M.,Guo Rishu,Yue Xiaohong,Penumarti Anusha,Qaqish Bahjat,Li Quefeng,Kulis Michael D.,Burks A. Wesley

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference21 articles.

1. The global burden of illness of peanut allergy: a comprehensive literature review;Lieberman;Allergy,2021

2. The natural history of persistent peanut allergy;Neuman-Sunshine;Ann Allergy Asthma Immunol,2012

3. Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis;Umasunthar;Clin Exp Allergy,2013

4. The economic impact of childhood food allergy in the United States;Gupta;JAMA Pediatr,2013

5. The Peanut Allergy Burden Study: impact on the quality of life of patients and caregivers;Nowak-Wegrzyn;World Allergy Organ J,2021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in immunotherapy approaches for allergic rhinitis;World Journal of Clinical Cases;2024-11-06

2. Pearls for practice from the 2023 joint task force anaphylaxis practice parameter;Current Opinion in Pediatrics;2024-09-04

3. Allergic Diseases and Mental Health;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

4. Food Sublingual Immunotherapy: Safety and Simplicity of a Real Food Updosing Protocol;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

5. In Silico Identification of Peanut Peptides Suitable for Allergy Immunotherapy in HLA-DRB1*03:01-Restricted Patients;Pharmaceuticals;2024-08-21